Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer
- Resource Type
- Article
- Source
- In
Annals of Oncology September 2008 19(9):1541-1546 - Subject
- Language
- ISSN
- 0923-7534